Press Release discussing the financial results of first quarter ended as on June 30, 2026 is attached.

fi A fi ® ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited) A C U T S CIN No. : L24100GJ2007PLC051093 You and us: chemistry’s apex July 24, 2026 The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5' Floor, Plot No. C-1, Dalal Street, Fort G-Block, Bandra Kurla Complex, Mumbai- 400 001 Mumbai -400051 Scrip Code: 543349 NSE Symbol: ACUTAAS Subject: Press Release pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dear Sir/Madam, In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Press Release discussing the financial results of first quarter ended as on June 30, 2026. This Press Release will be avaiiable on the website of the Company www.acutaas.com. Kindly take the same on record. Yours faithfully, For, ACUIAAS CHEMICALS LIMITED Ekta Kumari Srivastava Company Secretary & Compliance Officer Encl: Press Release . +9175730 15366, +91 72279 77744 Q Registered Office: Plot No. 440/4, 5 & 6, % info@acutaas.com Road No. 82/A, GIDC Sachin, . @ www.acutaas.com Dist. Surat - 394230, Gujarat, India PRESS RELEASE For Immediate dissemination Acutaas Chemicals Limited reports Q1 FY27 Results Q1 FY27 Revenue from Operation at ₹3,297mn, up 59.1% YoY Q1 FY27 PAT at ₹750mn, up 70.4% YoY; PAT Margins at 22.7% Surat, July 24, 2026: Acutaas Chemicals Limited (BSE: 543349, NSE: ACUTAAS), a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, today announced financial results for the quarter ended June 30, 2026. Consolidated Financial Results – Q1 FY27: Particulars (Rs. Mn) Q1FY27 Q1FY26 YoY Q4FY26 QoQ Revenue from Operations 3,297 2,072 59.1% 4,328 -23.8% Gross Profit 1,909 1,103 73.0% 2,683 -28.8% Gross Margin 57.9% 53.2% 62.0% EBITDA 1,131 509 122.1% 1,835 -38.4% EBITDA Margin 34.3% 24.6% 42.4% PAT 750 440 70.4% 1,343 -44.2% PAT Margin 22.7% 21.2% 31.0% Commenting on results, Mr. Naresh Patel, Executive Chairman & Managing Director, Acutaas Chemicals Limited, said: “We have started the year on a strong note, with revenue from operations growing 59.1% YoY to Rs. 3,297 mn — reflecting the agility of our business model and our ability to keep delivering to customers, on time and without compromise. We have also been certified as a Great Place to Work — a recognition of the culture of trust, collaboration and pride our people have built, and a proud validation of the team behind all we have achieved. We have further received the Responsible Care certification from the Indian Chemical Council — the industry’s commitment to the highest standards of safety, health and environmental performance — reaffirming our resolve to grow responsibly and sustainably. Overall, we remain confident of delivering 25% revenue growth for the full year with stable margins.” Key Results & Business Highlights (Q1FY27 Consolidated): ✓ Revenue from operations for Q1FY27 grew by 59.1% YoY to Rs. 3,297 mn ✓ The gross margin for the quarter improved to 57.9% up 466 bps YoY ✓ EBITDA for the quarter came at Rs. 1,131 mn up 122.1% YoY ✓ EBITDA margin for the quarter was at 34.3% as compared to 24.6% in Q1FY26 PRESS RELEASE For Immediate dissemination ✓ PAT for the quarter was Rs. 750 mn up 70.4% as compared to PAT of Rs. 440 mn in Q1FY26 ✓ The PAT margin for the quarter was at 22.7% up 151 bps YoY ABOUT ACUTAAS CHEMICALS LIMITED: Acutaas Chemicals Limited is a speciality chemicals manufacturer serving a wide range of industries, including pharmaceuticals, semiconductors, battery chemicals, personal care, agrochemicals, and fine chemicals. Our core strength lies in the research-driven development and manufacturing of advanced pharmaceutical intermediates used in both regulated and generic APIs, as well as intermediates for New Chemical Entities (NCEs). We are also expanding our portfolio to include high-value speciality chemicals for emerging technologies such as battery materials, semiconductor, and next-generation electronic applications. CAUTIONARY STATEMENT: This press release contains certain forward-looking statements. Any forward-looking statement applies only on the date of this press release. By their nature, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may or may not occur in the future and as a result of which the actual results and performance may differ substantially from the expected future results or performance expressed or implied in the forward-looking statements. No warranties or representations are made as to the accuracy, achievement, or reasonableness of such statements, estimates or projections, and Acutaas Chemicals Limited has no obligation to update any such information or to correct any inaccuracies herein or omission here from which may become apparent. For details, please contact: Investor Relations at Acutaas Chemicals Registered Office Limited Plot no. 440/4, 5 & 6, Road No. 82/A, Senior Manager – Investor Relations GIDC Sachin, Surat- 394230 Mr. Rahul Thakur CIN: L24100GJ2007PLC051093 Rahul.thakur@acutaas.com ISIN: INE00FF01025 NSE Code: ACUTAAS BSE CODE: 543349 Website: www.acutaas.com